It seems difficult to find any stakeholders in the orphan drug industry favorable to eliminating the fiscal incentives for orphan drug development. And that includes …
It seems difficult to find any stakeholders in the orphan drug industry favorable to eliminating the fiscal incentives for orphan drug development. And that includes …